CD86 and neoplasm: Although YAP1 has tumor-suppressive characteristics, it is relevant to take into account that this may lead to transcriptional activation of the oncogene JAG1. Finally, through the genomic interaction network, we could identify a potential dysregulation of the CD28-CD86-CTLA4 axis in the different lymphoid neoplasms cancer cell lines.